Abstract:
Six novel potential PARP1 inhibitors were identified by means of substructure search and molecular docking into PAPR1 active site; one compound (STK970217) potentiated the cytotoxicity of doxorubicin in hepatocellular carcinoma HepG2 cells being non-cytotoxic as a single agent, while three other identified compounds inhibited the growth of HepG2 cells both individually and in combination with doxorubicin.
Document Type:
Article
Language: English
Citation:
T. V. Rakitina, A. A. Zeifman, F. N. Novikov, O. V. Stroganov, V. S. Stroylov, I. Svitanko, A. Frank-Kamenetskii, G. G. Chilov, “Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro”, Mendeleev Commun., 25:5 (2015), 364–366
Linking options:
https://www.mathnet.ru/eng/mendc2410
https://www.mathnet.ru/eng/mendc/v25/i5/p364
This publication is cited in the following 3 articles:
Xiao‐Han Gao, Jun Yuan, Xiao‐Xia Zhang, Rui‐Cang Wang, Jie Yang, Yan Li, Jie Li, “Exploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis‐Related Genes”, Cancer Reports, 8:3 (2025)
Ming Fang Hsu, Yen Sheng Tyan, Yu Chen Chien, Ming Wei Lee, “Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent”, Sci Rep, 8:1 (2018)
V. V. Abzianidze, K. P. Bolshakova, D. S. Prokofieva, A. O. Berestetskiy, V. A. Kuznetsov, Yu. G. Trishin, “Synthesis of 7-(4-methylphenyl)thiomethyl and 7-morpholylmethyl derivatives of natural phaeosphaeride A and their cytotoxic activity”, Mendeleev Commun., 27:1 (2017), 82–84